HCPLive

Related Tags

MR-US Fusion Targeted Biopsy Ups Detection of Prostate Cancer

 
THURSDAY, Dec. 13 (HealthDay News) -- Targeted biopsy of suspected prostate cancer lesions, identified using magnetic resonance-ultrasound (MR-US) fusion, increases prostate cancer detection and detects aggressive tumors that may be missed by conventional biopsy, according to a study published in the January issue of The Journal of Urology.

Geoffrey A. Sonn, M.D., from the University of California Los Angeles, and colleagues used MR-US fusion prostate biopsy in 171 men (median age, 65 years) undergoing biopsy as part of active surveillance (106 men) or due to increased prostate-specific antigen levels with a prior negative conventional biopsy (65 men). MR-US fusion prostate biopsy locates lesions by magnetic resonance imaging (MRI) and fuses it with real-time ultrasound to generate a three-dimensional prostate model to allow targeted sampling. The men also had conventional systematic biopsies taken.

The researchers identified prostate cancer in 53 percent of men, of whom 38 percent had cancer with Gleason grade 7 or greater. Of these highly-aggressive cancers, 38 percent were detected only by targeted biopsy. Of the 16 men with the highest level of suspicion by MRI (image grade 5 target), 94 percent had prostate cancer.

"Prostate lesions identified on MRI can be accurately targeted with MR-US fusion biopsy in a clinic setting using local anesthesia," Sonn and colleagues conclude. "Targeted prostate biopsy has the potential to improve the diagnosis of prostate cancer and may aid in the selection of patients for active surveillance and focal therapy."
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2012 HealthDay. All rights reserved.
 
 

Most Popular

Recommended Reading

A recent study looked into the neural functions affected by ibuprofen and found some connections that may soon lead to a much greater understanding of the greatest pain mitigator of them all: the brain.
Discontinuation of multiple sclerosis medication saw nearly 2 in 5 patients experience some form of increased disease activity, according to research from NYU Langone Medical Center.
Weighing the pros and cons of prescription opioid use for chronic pain is an ongoing battle, and new research may have just added to the list of disadvantages.
There is considerable regional variation in thrombolysis treatment for ischemic stroke, according to a study published online June 2 in Stroke.

$vAR$